BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 34572373)

  • 1. The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis.
    Chai JY; Sugumar V; Alshawsh MA; Wong WF; Arya A; Chong PP; Looi CY
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
    Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
    J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened.
    Pietrobono S; Gagliardi S; Stecca B
    Front Genet; 2019; 10():556. PubMed ID: 31244888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors.
    Rimkus TK; Carpenter RL; Qasem S; Chan M; Lo HW
    Cancers (Basel); 2016 Feb; 8(2):. PubMed ID: 26891329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoproteomics of short-term hedgehog signaling in human medulloblastoma cells.
    Scheidt T; Alka O; Gonczarowska-Jorge H; Gruber W; Rathje F; Dell'Aica M; Rurik M; Kohlbacher O; Zahedi RP; Aberger F; Huber CG
    Cell Commun Signal; 2020 Jun; 18(1):99. PubMed ID: 32576205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
    Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
    Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy.
    Peer E; Tesanovic S; Aberger F
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30991683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog-GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO Inhibition.
    Peer E; Aichberger SK; Vilotic F; Gruber W; Parigger T; Grund-Gröschke S; Elmer DP; Rathje F; Ramspacher A; Zaja M; Michel S; Hamm S; Aberger F
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line.
    Werminghaus P; Haase M; Hornsby PJ; Schinner S; Schott M; Malendowicz LK; Lammers BJ; Goretzki PE; Müller-Mattheis V; Markus Giessing ; Willenberg HS
    J Steroid Biochem Mol Biol; 2014 Jan; 139():7-15. PubMed ID: 24063979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteostasis in the Hedgehog signaling pathway.
    Liu A
    Semin Cell Dev Biol; 2019 Sep; 93():153-163. PubMed ID: 31429406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors.
    Pietrobono S; Stecca B
    Cells; 2018 Dec; 7(12):. PubMed ID: 30558232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium.
    Kim KH; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Chung YS; Kim SH
    Pathol Int; 2009 May; 59(5):279-87. PubMed ID: 19432668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog signaling pathway inhibitors: an updated patent review (2015-present).
    Quaglio D; Infante P; Di Marcotullio L; Botta B; Mori M
    Expert Opin Ther Pat; 2020 Apr; 30(4):235-250. PubMed ID: 32070165
    [No Abstract]   [Full Text] [Related]  

  • 14. GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis.
    Hu MC; Mo R; Bhella S; Wilson CW; Chuang PT; Hui CC; Rosenblum ND
    Development; 2006 Feb; 133(3):569-78. PubMed ID: 16396903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance.
    Palle K; Mani C; Tripathi K; Athar M
    Cancers (Basel); 2015 Nov; 7(4):2330-51. PubMed ID: 26633513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog related protein expression in breast cancer: gli-2 is associated with poor overall survival.
    Im S; Choi HJ; Yoo C; Jung JH; Jeon YW; Suh YJ; Kang CS
    Korean J Pathol; 2013 Apr; 47(2):116-23. PubMed ID: 23667370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells.
    Miele E; Po A; Begalli F; Antonucci L; Mastronuzzi A; Marras CE; Carai A; Cucchi D; Abballe L; Besharat ZM; Catanzaro G; Infante P; Di Marcotullio L; Canettieri G; De Smaele E; Screpanti I; Locatelli F; Ferretti E
    BMC Cancer; 2017 Jul; 17(1):488. PubMed ID: 28716052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting GLI factors to inhibit the Hedgehog pathway.
    Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
    Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.
    Li N; Truong S; Nouri M; Moore J; Al Nakouzi N; Lubik AA; Buttyan R
    Oncogene; 2018 Apr; 37(17):2313-2325. PubMed ID: 29429990
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.